The latest scientific articles on TAVI published on our website

01- TAVR and Anticoagulation: Direct Anticoagulant Agents or Vitamin K Inhibitors? In some patients, using an anticoagulant agent is not an option, it is just prescribed. Based on the French TAVR registry, this research compared long-term mortality, bleeding, and ischemic events after valve implantation. A comparison was made between TAVR and direct vs. classic anticoagulant agents—good old proven and reversible vitamin K inhibitors. Read also HERE 02-<a href="https://solaci.org/en/2021/10/05/the-latest-scientific-articles-on-tavi-published-on-our-website/" title="Read more" >...</a>

The most read scientific papers of September in interventional cardiology

01- ESC 2021 | Updated European Society of Cardiology Guidelines for the Management of Valvular Heart Disease Early intervention in asymptomatic valvular heart disease, age recommendations to decide between TAVR and surgery for aortic stenosis, and a push in favor of transcatheter repair in secondary mitral regurgitation are some of the new modifications to the European<a href="https://solaci.org/en/2021/10/01/the-most-read-scientific-papers-of-september-in-interventional-cardiology/" title="Read more" >...</a>

La revascularización incompleta se asocia a mortalidad en el TAVI

Thrombotic and Bleeding Risk after TAVR: Quick Tips to Stay Up to Date

Transcatheter aortic valve replacement (TAVR) is an increasingly frequent option for patients with severe aortic stenosis across the entire risk spectrum.  However, TAVR involves bleeding and thrombosis risk and therefore calls for an optimal adjuvant treatment.  Any scheme is complex if we take into account most patients undergoing TAVR are generally elderly and have multiple<a href="https://solaci.org/en/2021/09/21/thrombotic-and-bleeding-risk-after-tavr-quick-tips-to-stay-up-to-date/" title="Read more" >...</a>

SOLACI-CACI 2021 | Day 1: Main Arena Auditorium

✔️ Day 1, SOLACI-CACI 2021 ✔️ Main Arena Auditorium 👨‍🏫 Program: 06:20 – TCT@SOLACI-CACI 2021 Session – “The Future of PCI” 01:33:19 – PCR@SOLACI-CACI 2021 Session 👉 How to manage Coronary Artery Disease in patients with Severe Aortic Stenosis eligible for TAVI? 👉 How to predict, how to avoid peri-procedural coronary obstruction during a TAVI<a href="https://solaci.org/en/2021/09/15/solaci-caci-2021-day-1-main-arena-auditorium/" title="Read more" >...</a>

SOLACI-CACI 2021 | EuroPCR Session

✔️ Watch the complete PCR in the SOLACI-CACI 2021 Congress. 👨‍🏫 Program: 👉 How to manage Coronary Artery Disease in patients with Severe Aortic Stenosis eligible for TAVI? 04:51 – How does Coronary Artery Disease impact decision-making process of the Heart Team for patients with symptomatic severe AS? – Round Table Discussion 10:59 – ACTIVATION<a href="https://solaci.org/en/2021/09/14/solaci-caci-2021-europcr-session/" title="Read more" >...</a>

SOLACI-CACI 2021 | Leading with Evidence, Choosing With Confidence – MICROPORT Symposium

✔️ MICROPORT Symposium in the SOLACI-CACI 2021 Virtual congress.✔️ Topic: Leading with evidence, choosing with confidence. 👨‍🏫 Program: 00:05 – Opening & Welcome – Dr. José Mangione. 01:10 – MicroPort Company Introduction – William Krinickas. 10:05 – TARGET AC 4-year results from TARGET all comers trial – Dr. Alexandra Lansky. 29:43 – Four-year clinical outcomes<a href="https://solaci.org/en/2021/09/13/solaci-caci-2021-leading-with-evidence-choosing-with-confidence-microport-symposium/" title="Read more" >...</a>

The Most Read Articles in August in Interventional Cardiology

01- Best Revascularization Strategy in Patients with Left Ventricular Deterioration Multivessel disease associated to ventricular function deterioration is challenging in terms of risk, when choosing a revascularization strategy.  Read also HERE 02- SOLACI Renewed Authorities During the SOLACI-CACI 2021 Congress After a massive event attended by thousands of people, the Latin American Society of Interventional Cardiology renewed its authorities for<a href="https://solaci.org/en/2021/09/10/the-most-read-articles-in-august-in-interventional-cardiology/" title="Read more" >...</a>

El acceso radial se asocia a menor mortalidad y menor sangrado en los pacientes cursando un infarto con supradesnivel del segmento ST que reciben angioplastia primaria.

Large Differences between Focal and Diffuse Patterns of Stable CAD

PCI is far more successful at reducing ischemia when treating focal stable coronary artery disease (CAD). However, there were no differences in symptoms between both types of CAD.  Physiological assessment with pressure wire pullback can be used to distinguish focal vs diffuse CAD, even though the relevance of this distinction has not been looked at<a href="https://solaci.org/en/2021/08/19/large-differences-between-focal-and-diffuse-patterns-of-stable-cad/" title="Read more" >...</a>

SOLACI-CACI 2021 | International Sessions with the Most Renowned Societies Worldwide

  INTERNATIONAL SESSIONS WITH THE MOST RENOWNED SOCIETIES WORLDWIDE Appealing sessions on the most relevant current topics in interventional cardiology will be at the forefront of a virtual, interactive event you do not want to miss! Save the date: August 2-6, 2021 Register now for FREE Learn more about the international joint sessions featured in<a href="https://solaci.org/en/2021/07/23/solaci-caci-2021-international-sessions-with-the-most-renowned-societies-worldwide/" title="Read more" >...</a>

TAVR Durability Becomes Irrelevant after TRANSIT Outcomes

The international registry TRANSIT has shown treating degenerated transcatheter aortic valves (TAVs) with a second TAVR is safe and effective. These finding are of crucial importance to the definite adoption of TAVR in the lower risk, younger population.  Transcatheter aortic valve replacement (TAVR) has determined a paradigm shift in severe aortic stenosis treatment.  Technological innovation<a href="https://solaci.org/en/2021/07/06/tavr-durability-becomes-irrelevant-after-transit-outcomes/" title="Read more" >...</a>

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31